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Background: An increasing number of studies have implicated the microbiome in certain diseases, especially
chronic diseases. In this study, the bacterial communities in the sputum of pulmonary tuberculosis patients were
explored. Total DNA was extracted from sputum samples from 31 pulmonary tuberculosis patients and respiratory
secretions of 24 healthy participants. The 16S rRNA V3 hyper-variable regions were amplified using bar-coded
primers and pyro-sequenced using Roche 454 FLX.
Results: The results showed that the microbiota in the sputum of pulmonary tuberculosis patients were more
diverse than those of healthy participants (p<0.05). The sequences were classified into 24 phyla, all of which were
found in pulmonary tuberculosis patients and 17 of which were found in healthy participants. Furthermore, many
foreign bacteria, such as Stenotrophomonas, Cupriavidus, Pseudomonas, Thermus, Sphingomonas, Methylobacterium,
Diaphorobacter, Comamonas, and Mobilicoccus, were unique to pulmonary tuberculosis patients.
Conclusions: This study concluded that the microbial composition of the respiratory tract of pulmonary
tuberculosis patients is more complicated than that of healthy participants, and many foreign bacteria were found
in the sputum of pulmonary tuberculosis patients. The roles of these foreign bacteria in the onset or development
of pulmonary tuberculosis shoud be considered by clinicians.
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Chronic pulmonary tuberculosis poses a global health
emergency. It has been known for many centuries and is
mainly caused by the bacillus Mycobacterium tuberculosis.
Many reports have revealed co-infection with different
strains or species of Mycobacterium in pulmonary tuber-
culosis patients. Mixed infection with Beijing and non-
Beijing strains of M.tuberculosis [1] has been reported to
mediate the increased reinfection rate in regions with a
high incidence of tuberculosis. Similarly, MAC (Mycobac-
terium avium complex) and M.tuberculosis coexist in
some patients with combined mycobacterial infections [2].
The systems biology concept of persistent infection is that
infectious diseases reflect an equilibrium between the host
and the pathogen that is established and maintained by a
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reproduction in any medium, provided the oracross scales that range from molecular to cellular, to
whole organism and population levels [3].
The development of nucleotide sequencing has helped
reveal the importance of microbiota to human health [4].
For example, community and microbial ecology-based
pathogenic theories have been introduced to explain the
relationship between dental plaque and the host [5]. The
urine microbiomes of men with sexually transmitted in-
fection were found to be dominated by fastidious, an-
aerobic and uncultivable bacteria [6]. Furthermore, the
microbiota interact with nutrients and host biology to
modulate the risk of obesity and associated disorders,
including diabetes, obesity inflammation, liver diseases
and bacterial vaginosis (BV) [7-10]. Patients with neo-
natal necrotising enterocolitis have lower microbiota
diversity, which is asscociated with an increase in the
abundance of Gammaproteobacteria [11]. Ichinohe et al
revealed that microbiota can regulate the immune defence
against respiratory tract influenza A virus infection [12].
Ehlers and Kaufmann also emphasised the association. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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variability of the gut microbiome [13]. In light of the
recent discovery of cystic fibrosis associated lung
microbiota, Delhaes and Monchy et al discussed the
microbial community as a unique pathogenic entity
[14]. Huang and Lynch emphasised that microbiota, as
a collective entity, may contribute to pathophysiologic
processes associated with chronic airway disease [15].
Robinson et al also suggested the conservation or res-
toration of the normal community structure and func-
tion of host-associated microbiota should be included
in the prevention and treatment of human disease [16].
In summary, microbiota are very important to human
health, Understanding the microbial composition in the
respiratory tract of pulmonary tuberculosis patients
may enhance our awareness of microbiota as a collect-
ive entity or even collective pathogenic entity, and the
role this entity plays in the onset and development of
pulmonary tuberculosis.
In this work, we collected 31 sputum samples from
pulmonary tuberculosis patients from Shanghai Pulmon-
ary Hospital, and 24 respiratory secretion samples
from healthy participants in Shanghai, China as con-
trols, and investigated the composition of the micro-
biota in the lower respiratory tract of pulmonary
tuberculosis patients.Figure 1 Bacterial communities grouped by individual. Each terminal b
enrolled subject. All nodes were recovered at 100% using the Jackknife me
participants, while those beginning with “TB” represent samples from patieResults and discussion
Results
Sequence diversity
The 454 pyro-sequencing method was used to analysis a
total of 71928 PCR amplicons in the samples from pul-
monary tuberculosis patients and healthy participants,
The amplicons averaged approximately 200 bp in length,
and the average number of sequences per sample was
1307.8. The mean Shannon diversity and evenness indices
in the pulmonary tuberculosis samples were 6.1926 (SD,
0.8093) and 0.9615 (SD, 0.0177), respectively. Both indices
were significantly higher than those in the healthy partici-
pants, which were 5.5145 (SD, 0.6545) (p=0.006) and
0.9341 (SD, 0.0216) (p=0.000) , respectively.
Clustering analysis of the respiratory tract microbiota can
separate healthy participants from pulmonary tuberculosis
patients
The similarities between the respiratory tract secretion
microbiota of the healthy participants and sputum micro-
biota of the pulmonary tuberculosis patients were esti-
mated by calculating UniFrac distances. Figure 1 shows
that the healthy participants were clustered together, while
the pulmonary tuberculosis patients were divided into
several different sub-branches.ranch represents the total bacterial community detected in one
thod. Names beginning with “N” represent samples from healthy
nts with pulmonary tuberculosis.
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ate analysis (PCoA) of the UniFrac distance demonstrated
a strong clustering of healthy participants away from pul-
monary tuberculosis patients. To better characterise the
sputum microbiomes, the sequences were sorted to the
genera level. A total 614 genera were observed; 235
genera were observed in healthy participants, and 564
genera were found in pulmonary tuberculosis patients,
although more than half of these accounted for only a
small fraction of the total sequences. As shown in Figure 3,
Streptococcus, Granulicatella, Actinomyces, Prevotella, and
Veillonella were predominant in the microbiota of both
healthy participants and pulmonary tuberculosis patients.
In contrast, Anoxybacillus, Klebsiella, Acinetobacter, Pilibac-
ter, Abiotrophia, Paucisalibacillus, and Rothia were more
abundant in pulmonary tuberculosis patients than healthy
participants. Neisseria, Porphyromonas, TM7_genera_incer-
tae_sedis, Parvimonas, Campylobacter, Haemophilus, and
Fusobacterium were less common in pulmonary tubercu-
losis patients than healthy participants. Furthermore,
Stenotrophomonas, Cupriavidus, Pseudomonas, Thermus,
Sphingomonas, Brevundimonas, Brevibacillus, Methylo-
bacterium, Diaphorobacter, Comamonas, Mobilicoccus,Figure 2 UniFrac community comparison of healthy participants and
were clustered using un-weighted UniFrac. The percentage of variation exp
circles with names beginning with “N” represent samples from healthy par
patients with pulmonary tuberculosis.and Fervidicoccus were unique to and widespread among
the pulmonary tuberculosis patients.
The phylum level composition of respiratory microbiomes
A total of 24 phyla were detected in the pulmonary tuber-
culosis samples, while 17 phyla were detected in healthy
participants. Actinobacteria, Bacteroidetes, Proteobacteria,
and Crenarchaeota were widely and abundantly distrib-
uted among nearly all of the samples. Firmicutes (37.02%),
Bacteroidetes (29.01%), Proteobacteria (16.37%), Crenarch-
aeota (3.16%), and Actinobacteria (2.89%) were common
in the healthy participants, while Firmicutes (41.62%), Bac-
teroidetes (7.64%), Proteobacteria (17.99%), Actinobacteria
(21.20%), and Crenarchaeota (7.5%) were common in the
pulmonary tuberculosis patients. Chlamydiae, Chloroflexi,
Cyanobacteria/Chloroplast, Deinococcus-Thermus, Elusi-
microbia, Euryarchaeota, SR1, Spirochaetes, Synergistetes,
and Tenericutes were found in both the healthy partici-
pants and pulmonary tuberculosis patients, although they
were rare in some samples. Aquificae, Caldiserica, Gem-
matimonadetes, Lentisphaerae, Planctomycetes, Thermo-
desulfobacteria, and Verrucomicrobia were unique to the
pulmonary tuberculosis samples. Moreover, in healthypatients with pulmonary tuberculosis. The sputum microbiomes
lained by each principal component is indicated on the axis. The
ticipants, while those beginning with “TB” correspond to samples from
Figure 3 Hierarchical clustering of sputum microbial composition at the genus level. The names of some of the most abundant genera
corresponding to terminal taxa depicted in the heatmap are listed to the right of the figure. Subjects listed at the top and right of the heatmap
indicate microbiome and genus relationships, respectively. Names beginning with “N” represent samples from healthy participants, while those
beginning with “TB” correspond to samples from patients with pulmonary tuberculosis.
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Fusobacteria accounted for 0.01%, 29.01% and 8.06%, re-
spectively. However, in pulmonary tuberculosis patients,
Deinococcus-Thermus increased to 0.93%, Bacteroidetes,
and Fusobacteria decreased to 7.64% and 1.35%, respectively.
Several genera were uniquel to the respiratory tracts of
pulmonary tuberculosis patients
Many genera were unique to in the sputum of pulmonary
tuberculosis patients. As shown in Figure 3 and Table 1,
Phenylobacterium, Stenotrophomonas, Cupriavidus, and
Pseudomonas were found in nearly half of the tuberculosis
patients we enrolled; furthermore, their total copies
accounted for more than 1% of the total sequences from
the sputum of pulmonary tuberculosis patients. Other
genera such as Sphingomonas,Mobilicoccus, Brevundimonas,
Brevibacillus, and Diaphorobacter were much more widely
detected in pulmonary tuberculosis patients, even though
they accounted for only a small number of sequences.Table 1 The distribution of some genera that were


























“α”: the number of pulmonary tuberculosis patients in whom sequences from
the corresponding genera were found.
“β”: the percentage of sequences of the corresponding genera of all
sequences found in pulmonary tuberculosis patients.Several rare genera were present in the sputum of pulmonary
tuberculosis patients, such as Thermus, Pelomonas, Methylo-
bacterium,Comamonas, Lactobacillus,Thermobacillus, Auri-
tidibacter, Lapillicoccus, and Devriesea.
Discussion
This study provides the first report on the microbial
composition of the lower respiratory tract of pulmonary
tuberculosis patients through the amplification of 16S
rRNA V3 hyper-variable regions using bar-coded pri-
mers and pyro-sequencing by Roche 454 FLX. The
results revealed that the microbial composition of the
lower respiratory tract in pulmonary tuberculosis
patients was more diverse (p<0.05) than in healthy parti-
cipants. Charlson et al reported that the microbial com-
position of saliva or pharynx secretions can reflect the
microbial communities in the lower respiratory tract,
and their results showed that there is a topographical
continuity of bacterial populations in the healthy human
respiratory tract [17]. Therefore, we chose to use sputum
and respiratory secretions in this study. However, the
best samples to use would be lung lavage fluid, which
perfectly reflects the lower microbial composition of the
respiratory tract. However, obtaining lung lavage fluid is
challenging, especially from healthy volunteers, because
lung lavage is painful and may even be harmful. This
may raise some ethical issues. In contrast, sputum and
respiratory secretions are easily obtained through non-
invasive, patients-friendly collection methods. Therefore,
we chose to analyse sputum and respiratory tract secre-
tions in our study. A previous study showed that fewer
than 1% of commensal organisms are able to grow under
laboratory conditions [18]; therefore, traditional cultivation-
based strategies for analysing the complexity and genetic
diversity of microbial communities are strongly biased.
However, modern methods, based on barcoded primers
and 454 pyro-sequencing allow for a thorough profiling
of the microbiota of each enrolled person [19,20]. Pub-
lished studies have also proved that the 16S rRNA V3
region sequence ideally suited for distinguishing all bac-
terial species to the genus level, except for closely
related Enterobacteriaceae [21].
The lower respiratory tract microbiome of pulmonary
tuberculosis patients was distinct from that of the
healthy participants. As shown in Figures 1 and 2, the
pulmonary tuberculosis patients formed a clear cluster
that was separate from the healthy participants based on
their microbiota. The phyla Bacteroidetes and Fusobac-
tera were significantly underrpresented in pulmonary tu-
berculosis patients compared with healthy participants,
while Actinobacteria was significantly overrepresented in
pulmonary tuberculosis patients. Moreover, bacteria
from the phylum Deinococcus-Thermus were widely dis-
tributed in pulmonary tuberculosis patients (15/31), but
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ficae, Caldiserica, Gemmatimonadetes, Lentisphaerae,
Planctomycetes, Thermodesulfobacteria and Verrucomi-
crobia were unique to pulmonary tuberculosis patients.
Figure 1 shows the genera Klebsiella, Pseudomonas and
Acinetobacter were more common in pulmonary tuber-
culosis patients, and we postulated that these bacteria
may aggravate the syndrome of pulmonary tuberculosis
in these patients. Table 1 shows that the genera Phenylo-
bacterium, Stenotrophomonas, Cupriavidus, Caulobacter,
Pseudomonas, Thermus and Sphingomonas were unique
to and widely distributed in patients with pulmonary
tuberculosis.
The respiratory tract microbiota of pulmonary tuber-
culosis patients, who suffer from chronic infection,
might be important in the pathogenicity of this disease.
The variety of bacterial genera especially the presence of
some abnormal genera in the sputum of pulmonary tu-
berculosis patients suggested that the pulmonary tuber-
culosis patient lung is an ecological niche that can
support the growth of a high variety of bacteria, espe-
cially certain abnormal bacteria. These abnormal genera
reportedly widespread in the environment, and some of
them have even been reported to be associated with
some infectious diseases [22-27]. Coenye et al also
reported the isolation of unusual bacteria from the re-
spiratory secretions of cystic fibrosis patients [22]. How-
ever, there are few reports on whether these organisms
can cause human disease. The lower respiratory tract is
an open system and can communicate freely with the
environment. We speculated that, in pulmonary tuber-
culosis patients, the lung micro-environment may be-
come more susceptible to colonisation by some foreign
microbes. The host response to pathogens is charac-
terised by rapid recognition combined with strong innate
(i.e., inflammatory) and adaptive immune responses,
enabling microbial eradication often at the cost of sig-
nificant tissue damage. Furthermore, the host is con-
stantly facing the challenge of discriminating between
symbiotic and pathogenic bacteria to organise an appro-
priately an adaptive response [28]. These responses lead
to the extensive fibrosis associated with recurring infec-
tions, possibly leading to a decreased clearance of lymph
and lymph-associated particles from the infected region
[29]. The lungs of individual patients typically contain
diverse lesions with varied overall structures that change
over time [3]. Ultimately, a strong host response to the
clearance of M. tuberculosis may produce local lesions in
the lung. This may in turn increase the possibility that
foreign bacteria will colonise or grow in the lower re-
spiratory tract. During the initial disease-causing inva-
sion of the lung by M. tuberculosis, a strong host
immune response may kill or clear some normal bacteria
in the lower respiratory tract of pulmonary tuberculosispatients. This may be why the populations of many nor-
mal bacteria are decreased or absent from the micro-
biota of the pulmonary tuberculosis patients. At the
same time, a strong host strong immune response
against the pathogen may damage or produce lesions in
the lung tissue, and consequently the micro-
environment of the lower respiratory tract may favour
colonisation or even host invasion by foreign microor-
ganisms. These foreign bacteria may cooperate with M.
tuberculosis to cuase additional damage to the lung tis-
sue. In this model, although M. tuberculosis plays a cen-
tral role in the disease, the other bacteria may assist in
the destruction of the lung tissue, especially in active tu-
berculosis. If M. tuberculosis eliminated promptly, how-
ever, lung funtion can be restored. Further investigation
will be required to determine whether pulmonary tuber-
culosis is the cause of increased foreign bacterial colon-
isation of the lower respiratory tract or vice versa (i.e.,
the presence of foreign bacteria aggravates the symp-
toms of pulmonary tuberculosis); is also possible that
both occur simultaneously.
Conclusions
This study demonstrated that the microbial composition
of the respiratory tract of pulmonary tuberculosis
patients was more complicated than that of healthy
volunteers, and many foreign bacteria were found in the
sputum of pulmonary tuberculosis patients. These for-
eign bacteria may participate in the onset or develop-
ment of pulmonary tuberculosis.
Methods
All of the procedures for the collection and handling of
patient samples and data were reviewed and approved
by the ethics committee of the Shanghai Pulmonary
Hospital and Shanghai Jiaotong University School of
Medicine, incompliance with the Helsinki Declaration of
the World Medical Association. All study subjects pro-
vided written informed consent to participate in the
study.
Specimens
A total of 31 pulmonary tuberculosis patients, ranging in
age 23 to 67 years old, with a age median of 39 years
and a male/female ratio of 19/12, were recruited from
the Shanghai Pneumonia Hospital. All patients were free
of HIV. The patients were clinically diagnosed with pul-
monary tuberculosis based on sputum smear, sputum
culture, and computed tomography results. The sputum
samples were collected after the patients had been
admitted to the hospital. A portion of the sputum sam-
ple was used for medical tests, and the remaining spu-
tum was preserved for DNA extraction after the patients
were confirmed to have pulmonary tuberculosis. Anti-
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pyrazinamide) and its efficiency as demonstrated by
computed tomography, were also considered to confirm
the diagnosis of pulmonary tuberculosis. None of the
patients had taken antibiotics for at least 3 months be-
fore sampling. Of the 31 patients tested, 12 were sputum
culture positive, 9 were sputum smear positive, 20 were
clinically diagnosed with bilateral tuberculosis, 7 were
clinically diagnosed with right pulmonary tuberculosis, 2
were clinically diagnosed with left lung tuberculosis, 1
was clinically diagnosed with tuberculosis pleurisy, and 1
was clinically diagnosed with tuberculosis bronchiectasis.
The healthy volunteers were recruited from the same
region as the tuberculosis patients. A total of 24 healthy
participants, ranging from 38 to 66 years old, with a me-
dian age of 55, and a male and female ratio of 13/11,
were recruited from Shanghai, China. The volunteers
had similar lifestyle and eating habits, nutritional status
and physical condition, were free of basic pulmonary
diseases, severe lung disease, severe oral disease, sys-
temic disease and other known diseases such as obesity
or diabetes, that could affect the microbial composition
of the respiratory tract. Volunteers with a history of
smoking or drinking were also excluded. The healthy
participants had not taken any antibiotics for at least
3 months before sampling. The samples from healthy
participants were a mixture of saliva and pharyngeal
secretions collected by deep coughing in the early morn-
ing before gargling. By coughing, the community that
was originally in the sputum was contaminated by the
normal flora of the oral cavity and pharynx. (The
detailed information of the pulmonary tuberculosis
patients and the healthy participants were showed in
Additional file 1).
Establishment of a pyro-sequencing library and pyro-
sequencing using the 454 platform
DNA extraction and PCR of the 16S rRNA V3 region
were performed as described in our previously published
article [20]. However, several additional modifications
were made. Fresh sputum samples were chosen soon
after routine tests confirmed the diagnosis of pulmonary
tuberculosis. After liquefaction at room temperature for
1 hour in a sterilised sodium hydroxide solution, 3 ml of
sample was aliquoted into three 1.5 ml Eppnedorf tubes,
pasteurised at 83°C for 30 min, and further extracted
using a Bacterial DNA kit (OMEGA, Bio-Tek, USA).
PCR enrichment of the 16S rRNAV3 hyper-variable region
was performed with the forward primer 5’-XXXXXXXX-
TACGGGAGGCAGCAG-3’ and the reverse primer 5’-XX
XXXXXX-ATTACCGCGGCTGCTGG-3’. The 5’ terminus
of each primer contained a different 8-base- oligonucleo-
tide tag (represented by “XXXXXXXX” in the primersequence), while the sequence after the hyphen was used
to amplify the sequences of the V3 end region.
To ensure that a sufficient quantity of PCR product
was amplified, a two-step PCR strategy was used. The
first step was carried out in a 25 μl reaction volume con-
taining 2.5 μl of PCR buffer (TAKARA), 0.625 U ExTaq
(TAKARA), 0.1 μl of BSA (TAKARA), and 2 μl of pri-
mer solution with 100 μmol of each forward and reverse
primer and 50 ng of extracted DNA as a template;
ddH2O was added to reach the final volume of the reac-
tion. Touchdown PCR was performed as follows: 5 min
at 94°C for initial denaturation, followed by 20 cycles of
1 min at 94°C for denaturation, 1 min at 65°C for
annealing and 1 minute at 72°C for extension, with the
annealing temperature decreasing by 0.5°C for each
cycle. The reaction volume in the second step of the
PCR was 50 μl and contained 5 μl of the product from
step one as a template. The reaction also included 5 μl
of PCR buffer (TAKARA), 1.25 U ExTaq (TAKARA), 0.2
μl of BSA (TAKARA), 24 μl of water and 200 μmol of
each barcoded forward and reverse primer. The amplifi-
cation was carried out for five cycles of 1 minute at 94°C
for denaturation, 1 minute at 55°C for annealing, and
1 minute at 72°C, with the temperature maintained at
20°C after the reaction was complete. Sequencing was
performed at the Chinese National Human Genome
Centre in Shanghai using a Roche 454 FLX instrument.
The resulting sequences were published as SRA acces-
sion SRA051957.
Phylogenetic and statistical analysis
The datasets were taxonomically grouped using the RDP
classifier (the naive Bayesian classifier of the Ribosomal
Database Project) at a confidence level of 90% [30]. The
gross sequencing data were first searched for the linker,
primers, and their reverse complements using the plat-
form provided by the centre. The identified primer
sequences were trimmed from each sequence read. Se-
quence reads that did not contain the 5’-end primer
were removed from the dataset. The same program was
also used for barcode identification. Barcodes were iden-
tified within the first 25 bases of the reads. Sequence
reads were binned into FASTA files based on their
barcodes.
Individual sequences were aligned using the Aligner
tool, and aligned sequences files for each sample were
processed by complete linkage clustering using distance
criteria. We used Uclust to cluster all of the sequences,
with a cut-off value of 97%. After clustering, we used a
representative sequence of each type as the OUT (oper-
ational taxonomic units), and the record of each OUT
sequence included the number of sequences and the
associated classification information. These data were
used to calculate the Shannon diversity and evenness
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etic microbial communities of the two types of samples
[31]. Statistical analyses were carried out in SPSS 19.0,
heatmaps were drawn in R, and Shannon diversity indi-
ces were estimated using Estimate S Win 8.20.
Additional file
Additional file 1: The detailed information of the pulmonary
tuberculosis patients and the healthy participants.
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